What is Rituximab-abbs: Uses, Dosage, Side Effects and More

Rituximab-abbs is a biosimilar medication that helps treat certain blood cancers and autoimmune conditions by targeting specific cells in your immune system. This infusion therapy works by binding to a protein called CD20 found on B-cells, which are a type of white blood cell that can become problematic in various diseases.

Think of it as a targeted treatment that helps your body reset its immune response when it's not working properly. Your healthcare team will carefully monitor you throughout treatment to ensure you're getting the best possible care.

What is Rituximab-abbs?

Rituximab-abbs is a biosimilar version of the original rituximab medication, meaning it works nearly identically to the reference drug but is manufactured by a different company. It's a monoclonal antibody that specifically targets CD20 proteins on B-lymphocytes (a type of white blood cell).

The medication is given through an IV infusion, usually in a hospital or infusion center where medical staff can monitor you closely. It's part of a class of drugs called immunotherapy, which means it works with your immune system rather than against it.

Your doctor may recommend rituximab-abbs when other treatments haven't been effective enough or as part of a comprehensive treatment plan. The "abbs" part simply indicates the specific manufacturer's version of this well-established medication.

What is Rituximab-abbs Used For?

Rituximab-abbs treats several serious conditions that involve B-cells behaving abnormally in your body. Your doctor will determine if this medication is right for your specific situation based on your diagnosis and overall health.

Here are the main conditions this medication helps treat:

• Non-Hodgkin's lymphoma (a type of blood cancer affecting lymph nodes)
• Chronic lymphocytic leukemia (CLL), a slow-growing blood cancer
• Rheumatoid arthritis when other treatments haven't provided enough relief
• Granulomatosis with polyangiitis (GPA), a rare autoimmune condition affecting blood vessels
• Microscopic polyangiitis (MPA), another rare autoimmune blood vessel condition

In some cases, your doctor might also consider rituximab-abbs for other autoimmune conditions where B-cells are causing problems. Each situation is unique, and your treatment plan will be tailored specifically to your needs.

How Does Rituximab-abbs Work?

Rituximab-abbs works by attaching to CD20 proteins on the surface of B-cells, marking them for destruction by your immune system. This process helps reduce the number of problematic B-cells that are contributing to your condition.

Once the medication binds to these cells, several things happen. Your immune system recognizes the marked cells as targets and eliminates them through natural processes. This reduction in B-cells can help calm down overactive immune responses or reduce cancerous cell populations.

The effects aren't immediate, which is completely normal. It typically takes several weeks to months for you to notice improvements as your B-cell levels gradually decrease and your condition begins to respond to treatment.

This medication is considered quite potent, so your healthcare team will monitor you carefully throughout treatment. The strength of rituximab-abbs is one reason why it's effective for serious conditions, but it also means close medical supervision is essential.

How Should I Take Rituximab-abbs?

Rituximab-abbs is always given as an intravenous (IV) infusion in a medical facility, never as a pill or injection you'd give yourself at home. Your healthcare team will handle all aspects of preparation and administration.

Before your infusion, you'll typically receive pre-medications to help prevent allergic reactions. These might include antihistamines, acetaminophen, or corticosteroids. Your nurse will start these about 30-60 minutes before beginning the rituximab-abbs infusion.

The actual infusion usually takes several hours, starting slowly and gradually increasing the rate if you tolerate it well. Your first infusion often takes the longest, sometimes 4-6 hours, while subsequent infusions may be shorter if you don't experience reactions.

You don't need to fast before treatment, but eating a light meal beforehand can help you feel more comfortable during the long infusion process. Staying well-hydrated in the days leading up to treatment is also helpful.

Plan to spend most of the day at the treatment center, and consider bringing entertainment or having someone stay with you for support. Your medical team will monitor your vital signs and watch for any reactions throughout the entire process.

How Long Should I Take Rituximab-abbs For?

The duration of rituximab-abbs treatment varies significantly depending on your specific condition and how well you respond to therapy. Your doctor will create a personalized treatment schedule based on established protocols for your particular diagnosis.

For blood cancers like lymphoma, you might receive infusions once weekly for 4 weeks, then have a break, or receive them every 3 weeks for several cycles. The total treatment period could range from several months to over a year, depending on your response and the specific treatment protocol.

If you're being treated for rheumatoid arthritis, you'll typically receive two infusions given 2 weeks apart. Your doctor might recommend repeating this cycle every 6-12 months based on how your symptoms respond and return over time.

For rare autoimmune conditions like GPA or MPA, treatment schedules are often individualized. Some people need regular infusions for maintenance, while others may have longer periods between treatments once their condition is under control.

Your doctor will regularly assess your response through blood tests, imaging studies, and symptom evaluation. Based on these results, they'll adjust your treatment timeline to give you the best possible outcomes while minimizing unnecessary exposure to medication.

What Are the Side Effects of Rituximab-abbs?

Like all powerful medications, rituximab-abbs can cause side effects, though many people tolerate it reasonably well with proper medical supervision. Understanding what to expect can help you feel more prepared and know when to contact your healthcare team.

The most common side effects you might experience include:

• Infusion reactions like fever, chills, or nausea during or shortly after treatment
• Fatigue that may last for several days after infusion
• Low white blood cell counts, making you more susceptible to infections
• Headache or dizziness
• Muscle or joint aches
• Skin reactions like rash or itching
• Digestive issues such as nausea, vomiting, or diarrhea

These reactions are generally manageable with proper pre-medication and supportive care. Your medical team knows how to prevent and treat most of these side effects effectively.

More serious but less common side effects require immediate medical attention:

• Severe allergic reactions with difficulty breathing or swelling
• Signs of serious infections like persistent fever, unusual fatigue, or breathing problems
• Heart problems including irregular heartbeat or chest pain
• Liver problems indicated by yellowing of skin or eyes
• Kidney issues causing changes in urination or swelling

Rare but serious complications can include progressive multifocal leukoencephalopathy (PML), a brain infection, and tumor lysis syndrome in cancer patients. While these are uncommon, your healthcare team will monitor you carefully for early signs and take preventive measures when possible.

Who Should Not Take Rituximab-abbs?

Rituximab-abbs isn't suitable for everyone, and your doctor will carefully evaluate your medical history and current health status before recommending this treatment. Certain conditions make this medication too risky or potentially harmful.

You should not receive rituximab-abbs if you have:

• A known severe allergy to rituximab or any components of the medication
• An active, serious infection that your body is currently fighting
• Severe heart failure or recent heart attack
• Live virus vaccinations scheduled within the treatment period

Your doctor will use extra caution and may avoid this treatment if you have certain conditions that increase your risk of complications.

Conditions requiring careful consideration include:

• History of hepatitis B or C, as rituximab can reactivate these infections
• Compromised immune system from other medications or conditions
• History of heart disease or irregular heart rhythms
• Kidney or liver disease
• Recent or planned surgery
• Pregnancy or breastfeeding

If you're pregnant or planning to become pregnant, rituximab-abbs can potentially harm your developing baby. Your doctor will discuss alternative treatments or help you plan the timing of treatment around pregnancy. The medication can also pass into breast milk, so breastfeeding isn't recommended during treatment.

Rituximab-abbs Brand Names

Rituximab-abbs is marketed under the brand name Truxima in the United States. This biosimilar version contains the same active ingredient as the original rituximab (Rituxan) but is manufactured by a different pharmaceutical company.

The "abbs" designation refers to the specific manufacturer's suffix, which helps distinguish this biosimilar from other versions of rituximab that may be available. Your pharmacy and healthcare team will ensure you receive the correct formulation prescribed by your doctor.

Whether you receive Truxima or another version of rituximab, the therapeutic effects should be essentially equivalent. Your doctor will choose the most appropriate and accessible option based on your insurance coverage and treatment facility's preferences.

Rituximab-abbs Alternatives

Several alternative treatments may be available depending on your specific condition, though your doctor will determine the best option based on your individual circumstances and medical history.

For blood cancers, alternatives might include:

• Other monoclonal antibodies like obinutuzumab or ofatumumab
• Traditional chemotherapy regimens
• Targeted therapy drugs like ibrutinib or venetoclax
• Radiation therapy for localized disease
• Stem cell transplantation in appropriate cases

For autoimmune conditions like rheumatoid arthritis, your doctor might consider other options if rituximab-abbs isn't suitable for you.

These alternatives could include:

• Other biologic medications like TNF inhibitors (adalimumab, etanercept)
• JAK inhibitors such as tofacitinib or baricitinib
• Traditional disease-modifying antirheumatic drugs (DMARDs)
• Corticosteroids for short-term symptom control

The choice of alternative depends on many factors including your specific diagnosis, previous treatments, other medical conditions, and your personal preferences. Your healthcare team will work with you to find the most appropriate treatment option if rituximab-abbs isn't the right choice.

Is Rituximab-abbs Better Than Rituximab (Rituxan)?

Rituximab-abbs (Truxima) and original rituximab (Rituxan) are considered therapeutically equivalent, meaning they should work equally well for treating your condition. The main differences lie in manufacturing and cost rather than effectiveness.

Both medications contain the same active ingredient and work through identical mechanisms in your body. Clinical studies have shown that biosimilar rituximab produces similar treatment outcomes, safety profiles, and side effect patterns compared to the original formulation.

The primary advantages of rituximab-abbs are often economic. Biosimilar medications typically cost less than their reference products, which can make treatment more accessible and reduce healthcare costs. Your insurance may also prefer covering the biosimilar version.

From a treatment perspective, you shouldn't expect any difference in how well the medication works or how your body responds to it. Your doctor will choose between the two based on availability, cost considerations, and your treatment facility's preferences rather than differences in therapeutic effectiveness.

If you've previously received original rituximab and are switching to the biosimilar version, this transition is considered safe and shouldn't affect your treatment outcomes. Your healthcare team will monitor you just as carefully regardless of which version you receive.